Supported by

TAVI (Transcatheter aortic valve implantation)

Find all the latest content on TAVI published on this website.

TAVI, now an established, valid treatment for patients presenting with symptomatic severe aortic stenosis, has proven to be superior to medical treatment for inoperable patients whilst being a valid alternative to surgery in select, high-risk patients. This topic covers the newest devices and emerging data in TAVI as well as information on tools, devices and techniques such as vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography, understanding bleeding risks or patient selection. Use the filters below to access PCRonline resources.

Anatomy of the aortic valvar complex

View a detailed and comprehensive description of the anatomy of the aortic valvar complex as it pertains to TAVI.

View illustrated aortic valvar complex

Filtered By
TAVI

1626 results

From access to annulus: overcoming challenging anatomies

05 Dec 2023 – From GulfPCR-GIM 2023

Gain expertise in selecting the appropriate TAVI device for achieving stable deployment in a 90-degree horizontal aorta. Discover techniques for ensuring smooth deliverability, particularly when navigating through tight and tortuous anatomies. Additionally, learn strategies to prepare for future coronary access, irrespective of the height of the...

From access to annulus: overcoming challenging anatomies

How to manage paravalvular leaks?

04 Jan 2024 – From PCR London Valves 2023

Invited to talk about paravalvular leaks, Grzegorz Smolka, Patrick Calvert and Xavier Freixa begin by placing the subject in context, mentioning the frequency with which it is encountered in general practice.

Then, they distinguish between patients likely to benefit from paravalvular leak closure via transcatheter and those...

How to manage paravalvular leaks? - PCR London Valves 2023

Contemporary surgical & transcatheter treatment options for severe aortic regurgitation patients

05 Dec 2023 – From PCR London Valves 2023

Two cardiac surgeons, Hendrik Treede and Michael Reardon, and an echo specialist, Joao Cavalcante, have been invited to share their views on aortic regurgitation management.

So far, surgery remains the gold standard, and they explain why, by also comparing repair and replacement, before discussing the challenge that...

Contemporary surgical & transcatheter treatment options for severe aortic regurgitation patients  - PCR London Valves 2023

What does lifetime management mean for the valve patient?

10 Jan 2024 – From PCR London Valves 2023

Bettina Kirk, Alexandra Baer and John Webb discuss the question of lifetime management for valve disease patients, and begin by outlining the main difficulties involved, offering both an interventional cardiologist's and a nurse's perspective.

Then, they are considering how this lifetime management could be improved in the...

The remaining big questions in transcatheter tricuspid valve intervention - PCR London Valves 2023

How to anticipate, plan and perform a TAV-in-TAV?

25 Jan 2024 – From PCR London Valves 2023

By 2023, although TAVI has become a safe routine procedure, it is now its long-term durability and the planning of a second procedure, particularly in younger patients, that is causing concern.

Vinayak Bapat and Bernard Prendergast discuss how to anticipate any potential TAV-in-TAV, take into account any...

How to anticipate, plan and perform a TAV-in-TAV?

What is the optimal aortic valve choice in the younger patient: transcatheter or surgery?

29 Nov 2023 – From PCR London Valves 2023

Follow the discussion between Darren Mylotte, Kentaro Hayashida and Ole De Backer to better understand the concept of "young patients" and what it exactly implies, and analyze how best to bring these specific patients to the end of their still potentially long life, by choosing the...

What is the optimal aortic valve choice in the younger patient: transcatheter or surgery?

Navigating complexity: surgical valve degeneration and complex coronary artery disease in a multimorbid patient

14 Dec 2023

How would you treat this 83-year-old male patient with LM, MVD, RCA CTO, severely reduced EF, and constrictive surgical valve?

Sadeek Sidney Kanoun Schnur

Author

Sadeek Sidney Kanoun Schnur

Author

Albrecht Schmidt
Dr. Gabor G. Toth

Author

Gabor G. Toth
Navigating complexity: surgical valve degeneration and complex CAD in a multimorbid patient

Focus on aortic valves

22 Nov 2023 – From PCR London Valves 2023

Simon Redwood and Christopher Cook cover the top three highlights of the aortic track at #PCRLV 2023:

  • LIVE and recorded cases showcasing procedures from simple to highly complex.
  • Engaging discussions on TAV in TAV procedures to enhance our ability to effectively treat patients.
  • Long-term data and late trial results...
Highlights from PCR London Valves 2023 - Focus on aortic valves

Essentials of lifetime management of TAVI patients

21 Nov 2023 – From PCR London Valves 2023

Consult this session if you want to learn about the next generation transcatheter heart valve technology key features, procedural and clinical benefits, to learn tips and tricks for managing bicuspid and valve-in-valve interventions, and to understand procedural and clinical relevance of intermediate and XL sizes in...

Essentials of lifetime management of TAVI patients

VitaFlow - The electrically enable self-expanding TAVI valve

21 Nov 2023 – From PCR London Valves 2023

This session provides insights into the unique design and advantages of VitaFlow Liberty for TAVI. It covers techniques to minimize microdislodgement during the procedure, identifies situations and patient types most suitable for VitaFlow Liberty, and reviews early clinical results associated with this technology.

VitaFlow - The electrically enable self-expanding TAVI valve

Facing the challenges of resource shortages - An outlook into the future of TAVI?

21 Nov 2023 – From PCR London Valves 2023

Join this session to discover strategies for optimizing care quality and patient safety, especially in resource-constrained environments. Gain insights into variations in TAVI patient treatment across European countries, understanding the associated consequences. Engage in discussions exploring potential solutions to ensure long-term, high-quality patient care despite challenges...

Facing the challenges of resource shortages - An outlook into the future of TAVI?

Best contemporary clinical practice for TAVI

21 Nov 2023 – From PCR London Valves 2023

Watch this session if you wish to explore emerging trends for transcatheter aortic valve implantation in younger patients, the specific considerations for TAVI in individuals with an extended life expectancy, and examine how valve design and implantation techniques can impact long-term outcomes.

Best contemporary clinical practice for TAVI

Addressing remaining issues after TAVI: what to expect from the new generation?

21 Nov 2023 – From PCR London Valves 2023

Consult this session if you want to discuss the challenges of TAVI for lower-risk patients, and to capture the features of new TAVI devices.

Addressing remaining issues after TAVI: what to expect from the new generation?

Valve in valve - TAV in TAV - Part 2

21 Nov 2023 – From PCR London Valves 2023

Join us for this session, where complex cases shed light on the evolving landscape of valve-in-valve interventions: delve into the efficacy of THV-in-THV for addressing supra-skirtal leakage accompanied by intravascular hemolysis, learn more about the challenges of TAVI-in-TAVI with the deployment of SAPIEN3 Ultra in a...

Valve in valve - TAV in TAV - Part 2

TAVI - Coronary complications

21 Nov 2023 – From PCR London Valves 2023

Explore challenging situations in this session: witness the rare occurrence of coronary embolization resulting from a fractured biological surgical valve in an aortic valve-in-valve procedure, uncover the complexities surrounding the late presentation of cardiogenic shock after TAVR, navigate the unusual challenge of intermittent left main obstruction caused...

TAVI - Coronary complications

Aortic regurgitation - Part 3

21 Nov 2023 – From PCR London Valves 2023

Consult this session to gain valuable knowledge on approaches to address aortic regurgitation: uncover the clinical effectiveness of TAVR in managing aortic insufficiency associated with LVAD and delve into the comparison between echocardiography and magnetic resonance imaging for assessing device regurgitation in patients undergoing TAVI.

Aortic regurgitation - Part 3

Rare complications of structural intervention

21 Nov 2023 – From PCR London Valves 2023

Join us in this session for a look at rare and challenging scenarios in structural interventions: delve into the complexities of an ascending aorta mycotic aneurysm in a patient with a prior TAVI procedure, witness a unique case showcasing a misloaded self-expanding TAVR device, uncover the...

Rare complications of structural intervention

TAVI outcomes - Part 2

21 Nov 2023 – From PCR London Valves 2023

Explore the latest insights in TAVI outcomes with this session: delve into the pursuit of transatlantic harmonization in echocardiography core laboratory analysis and adjudication according to VARC3 guidelines, investigate the nuances of TAV deployment within an elliptical aortic root, uncover the clinical impact of multiple resheathing...

TAVI outcomes - Part 2

TAVI - Vascular complications

21 Nov 2023 – From PCR London Valves 2023

Learn valuable insights into vascular complications management and prevention during TAVI with this session: navigate the challenges of a post-TAVI common femoral artery occlusion in a patient with a previously implanted bioabsorbable closure device, witness the difficulties of common iliac artery stent dislodgment, explore the rare...

TAVI - Vascular complications

TAVI - complications

21 Nov 2023 – From PCR London Valves 2023

Because TAVI is not without risk, learn about bailout endovascular techniques to counter transcatheter aortic valve LV dislocation, analyze the cost of infectious complications caused by TAVR compared with SAVR, and discover how imaging can predict aortic root rupture or conduction abnormalities, among others.

TAVI - complications